Cerus Corp. (CERS)
2.285
-0.06
(-2.35%)
USD |
NASDAQ |
Oct 07, 16:00
2.285
0.00 (0.00%)
After-Hours: 17:49
Cerus EPS Diluted (Quarterly) : -0.0147 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.0147 |
| March 31, 2026 | -0.0084 |
| December 31, 2025 | -0.0114 |
| September 30, 2025 | -0.0001 |
| June 30, 2025 | -0.0298 |
| March 31, 2025 | -0.0412 |
| December 31, 2024 | -0.0136 |
| September 30, 2024 | -0.0158 |
| June 30, 2024 | -0.0312 |
| March 31, 2024 | -0.0532 |
| December 31, 2023 | -0.0073 |
| September 30, 2023 | -0.0402 |
| June 30, 2023 | -0.0735 |
| March 31, 2023 | -0.0876 |
| December 31, 2022 | -0.0768 |
| September 30, 2022 | -0.0479 |
| June 30, 2022 | -0.0474 |
| March 31, 2022 | -0.0704 |
| December 31, 2021 | -0.0527 |
| September 30, 2021 | -0.0724 |
| June 30, 2021 | -0.0897 |
| March 31, 2021 | -0.1034 |
| December 31, 2020 | -0.0859 |
| September 30, 2020 | -0.0849 |
| June 30, 2020 | -0.0905 |
| Date | Value |
|---|---|
| March 31, 2020 | -0.1046 |
| December 31, 2019 | -0.1184 |
| September 30, 2019 | -0.1275 |
| June 30, 2019 | -0.127 |
| March 31, 2019 | -0.1371 |
| December 31, 2018 | -0.1192 |
| September 30, 2018 | -0.1056 |
| June 30, 2018 | -0.1011 |
| March 31, 2018 | -0.1112 |
| December 31, 2017 | -0.1004 |
| September 30, 2017 | -0.1222 |
| June 30, 2017 | -0.1626 |
| March 31, 2017 | -0.1796 |
| December 31, 2016 | -0.13 |
| September 30, 2016 | -0.14 |
| June 30, 2016 | -0.18 |
| March 31, 2016 | -0.17 |
| December 31, 2015 | -0.1375 |
| September 30, 2015 | -0.17 |
| June 30, 2015 | -0.17 |
| March 31, 2015 | -0.17 |
| December 31, 2014 | -0.2561 |
| September 30, 2014 | -0.16 |
| June 30, 2014 | -0.16 |
| March 31, 2014 | -0.12 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| DexCom, Inc. | 0.6429 |
| Abbott Laboratories | 0.5324 |
| AngioDynamics, Inc. | -0.2735 |
| Alphatec Holdings, Inc. | -0.1647 |
| AtriCure, Inc. | 0.1832 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -2.982M |
| Revenue (Quarterly) | 57.44M |
| Total Expenses (Quarterly) | 60.38M |
| Enterprise Value | 492.64M |
| Gross Profit Margin (Quarterly) | 50.61% |
| Profit Margin (Quarterly) | -5.19% |
| Earnings Yield | -1.51% |
| Normalized Earnings Yield | -1.514 |